INTRODUCTION Acne is one of the most common conditions seen in the dermatology clinic, and the highest incidence is recorded during puberty. However, adult cases are also common. Although not…

INTRODUCTION Tumor necrosis factor-α (TNF-α) inhibitors—such as etanercept, infliximab and adalimumab—represent a powerful addition to the arsenal of treatments for psoriasis and psoriatic arthritis.1 However, several complications can occur with…

INTRODUCTION Central serous chorioretinopathy (CSC), also known as central serous retinopathy (CSR), is a visual impairment, often temporary, usually in a single eye, which mostly affects males in the age…

INTRODUCTION Nephrogenic systemic fibrosis (NSF) is a recently described systemic fibrosing disorder that develops in the setting of renal insufficiency. The primary manifestations are cutaneous, and include progressive, often symmetric,…

CASE REPORT A 7-year-old male was seen in pediatric dermatology clinic for a lifelong history of blisters and skin discoloration. His family described blisters on the left heel and left…

INTRODUCTION This edition of Resident Spotlight features Dr. Eva Volf's winning poster, “A Phase 2, Open-Label, Investigator-Initiated Study to Evaluate the Safety and Efficacy of Apremilast in Subjects with Recalcitrant…

A Biopsy Diagnosis? Clinical Clues and Patterns to Help Distinguish Cutaneous Metastases: Part II of II* *Part I of this review ran in the June 2011 issue.Specific Cutaneous Metastases Breast…

PSORIASIST Cell Repertoire Analysis of Immune Mediated Skin Diseases Sponsored by University of California, Davis. This study is designed to identify the cells of the immune system that cause skin…

La Roche Posay Introduces New Products La Roche-Posay has just introduced an array of products that target wrinkles, acne and hyperpigmentation. Redermic UV Intensive Daily Anti-Wrinkle Firming Fill-In Care with…

To the Editor: When the first hyaluronic acid (HA) soft tissue filler (Restylane, Medicis) was approved by the U.S. Food and Drug Administration almost eight years ago, our focus was…

The New Face of Fillers: Why Evidence and Experience Both CountTo the Editor: When the first hyaluronic acid (HA) soft tissue filler (Restylane, Medicis) was approved by the U.S. Food…

Approximately 40 years ago, immediate release (IR) tablet and capsulated delivery forms of minocycline and doxycycline were made available for prescription. These dosage forms resulted in a rapid release of…